Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yulin Leng
Observed names:
Yu-Lin Leng,
YuLin Leng,
yulin leng
Institution:
Chengdu University of Traditional Chinese Medicine
Observed institutions:
National Natural Science Foundation of China,
Chengdu University of Traditional Chinese Medicine,
Fuzhou University
ORCID:
0000-0003-3408-7768
Observed ORCID:
0000-0003-3408-7768
OpenAlex ID:
A5042788737
The potential of astragalus polysaccharide for treating diabetes and its action mechanism
2024
·
Shiyu Liu
, Luyao Wang
, et al.
·
Frontiers in Pharmacology
·
57
PDF
Chinese herbal medicine and active ingredients for diabetic cardiomyopathy: molecular mechanisms regulating endoplasmic reticulum stress
2023
·
Lianjun Ao
, Zhengtao Chen
, et al.
·
Frontiers in Pharmacology
·
20
PDF
Relationship between stroke and estimated glucose disposal rate: results from two prospective cohort studies
2024
·
Yutong Han
, Kexin Zhang
, et al.
·
Lipids in Health and Disease
·
19
PDF
The efficacy and safety of Chinese herbal medicine as an add-on therapy for type 2 diabetes mellitus patients with carotid atherosclerosis: An updated meta-analysis of 27 randomized controlled trials
2023
·
Zehua Zhang
, Yulin Leng
, et al.
·
Frontiers in Pharmacology
·
19
PDF
The efficacy and safety of dachaihu decoction in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis
2022
·
Zehua Zhang
, Yulin Leng
, et al.
·
Frontiers in Pharmacology
·
16
Preliminary Study of the Distinctive Mechanism of Shenqi Compound in Treating Rats with Type 2 Diabetes Mellitus by Comparing with Metformin
2023
·
Xiaoxu Fu
, Xiujuan Zhou
, et al.
·
Current Vascular Pharmacology
·
15
Puerarin as a multi-targeted modulator of lipid metabolism: molecular mechanisms, therapeutic potential and prospects for nutritional translation
2025
·
Shu Ou
, Qingzhi Liang
, et al.
·
Frontiers in Nutrition
·
10
PDF
Efficacy and safety of Chinese herbal medicine on blood glucose fluctuations in patients with type 2 diabetes mellitus: A protocol of systematic review and meta-analysis
2020
·
Yulin Leng
, Xiujuan Zhou
, et al.
·
Medicine
·
9
The efficacy and safety of Chinese herbal medicine Shen-Qi Hua-Yu formula in patients with diabetic lower extremity artery disease: Study protocol of a multi-center, randomized, double-blind, placebo-controlled trial
2020
·
Yulin Leng
, Hong Gao
, et al.
·
Medicine
·
7
The efficacy and safety of Ginkgo biloba L. leaves extract combined with ACEI/ARB on diabetic kidney disease: a systematic review and meta-analysis of 41 randomized controlled trials
2025
·
Zehua Zhang
, Shiyun Tang
, et al.
·
Frontiers in Pharmacology
·
6
PDF
Inhibited hypoxia-inducible factor by intraoperative hyperglycemia increased postoperative delirium of aged patients: A review
2024
·
Yutong Han
, Bing Ji
, et al.
·
Medicine
·
6
Exploration of SQC Formula Effect on Type 2 Diabetes Mellitus by Whole Transcriptome Profile in Rats
2021
·
Xiaoxu Fu
, Xiujuan Zhou
, et al.
·
Endocrine Metabolic & Immune Disorders - Drug Targets
·
6
Mendelian randomization analysis reveals causal factors behind diabetic nephropathy: evidence, opportunities, and challenges
2024
·
Qinchuan Huang
, Chen An
, et al.
·
Frontiers in Endocrinology
·
5
PDF
Efficacy, safety and therapeutic mechanism of Shen-Qi Xiao-Tan formula in the treatment of peripheral atherosclerosis in patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial protocol
2022
·
Yulin Leng
, Xiaoxu Fu
, et al.
·
BMC Complementary Medicine and Therapies
·
5
PDF
The Mitigatory Effect of Shen-Qi Compound on the Diabetic Thoracic Aortic Complications through Inhibiting the Inflammatory Microenvironment by miR-223-3p/RBP-J/IRF8 Axis
2022
·
Ye Tian
, Gang Xu
, et al.
·
Evidence-based Complementary and Alternative Medicine
·
4
PDF
Inhibition of high glucose-induced cardiac fibroblast activation: an effective treatment for diabetic cardiomyopathy using Chinese herbal medicine
2025
·
Bin Wan
, Jing Hu
, et al.
·
Frontiers in Pharmacology
·
3
PDF
Chinese herbal medicine Shenqi compound for early intervention in patients at high cardiovascular risk of type 2 diabetes mellitus: the protocol of a multicenter, randomized, double-blind, placebo-controlled trial
2024
·
Yulin Leng
, Zehua Zhang
, et al.
·
Frontiers in Cardiovascular Medicine
·
1
PDF
Integrated LC-MS/MS profiling, network pharmacology and experimental validation reveal inhibition of the IL-6/JAK2/STAT3 pathway by Shenqi Compound in comorbid chronic pancreatitis and type 2 diabetes mellitus
2026
·
Yi Su
, Heng Yang
, et al.
·
Journal of Ethnopharmacology
Peripheral blood HIF-1α levels in type 2 diabetes mellitus and their association with diabetic complications: a systematic review and meta-analysis
2026
·
Yi Su
, Yunhui Chen
, et al.
·
Frontiers in Endocrinology
PDF
The role of peripheral blood HIF-1α in pancreatic β-cell dysfunction and insulin resistance among patients with type 2 diabetes: a systematic review and meta-analysis
2026
·
Yi Su
, Rui Peng
, et al.
·
Frontiers in Nutrition
PDF
ShenQi Compound improves diabetes by modulating pancreatic mitochondrial energy metabolism in GK rats
2025
·
Jiushu yuan
, huixuan zhang
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Case report: Gitelman Syndrome With Type 2 Diabetes Caused by a New Homozygous Mutation of SLC12A3 (c.1567G>A) and Family Follow-up
2021
·
Dongqi Zhou
, Xiaoke Liu
, et al.
·
Research Square
Show more works
View as search
Works count:
22
Citation count:
208
H-index:
8
I10-index:
7
Year
Topic
Type